Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is This Biotech a Safe Stock to Buy?

TheMotleyFool

0 0

Is This Biotech a Safe Stock to Buy?Photo, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

Upon first glance, Axsome Therapeutics (NASDAQ: AXSM) doesn't exactly sound like a candidate for being a safe stock that's ready to buy today. At present, the biotech has no approved drugs nor any revenue. Nor does it have much cash on hand or any major collaborator to keep it afloat.

So how could it possibly be safe? The short answer is that all of the above is likely to change for the better. And it all boils down to one subtle clue that was disclosed recently.

Image source: Getty Images.

Source Fool.com

Like: 0

AXSM

Share